Bibliographic Details
| Title: |
Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2. |
| Authors: |
Gnant M; Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. michael.gnant@meduniwien.ac.at, Baselga J, Rugo HS, Noguchi S, Burris HA, Piccart M, Hortobagyi GN, Eakle J, Mukai H, Iwata H, Geberth M, Hart LL, Hadji P, El-Hashimy M, Rao S, Taran T, Sahmoud T, Lebwohl D, Campone M, Pritchard KI |
| Source: |
Journal of the National Cancer Institute [J Natl Cancer Inst] 2013 May 01; Vol. 105 (9), pp. 654-63. Date of Electronic Publication: 2013 Feb 19. |
| Publication Type: |
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: |
Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
